MaxCyte, Inc. (MXCT)
0.8403
-0.03
(-3.58%)
USD |
NASDAQ |
May 08, 12:57
MaxCyte Research and Development Expense (Annual) : 20.82M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| TELA Bio, Inc. | 9.22M |
| CONMED Corp. | 55.88M |
| Escalon Medical Corp. | 0.7531M |
| IRIDEX Corp. | 3.396M |
| Electromed, Inc. | 0.996M |